01—Abstract
Summary
Summary of the 10-Q filed October 28, 2025. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group (UNH) reported its third-quarter 2025 results, showcasing robust revenue growth of 12% year-over-year to $113.2 billiona, driven by strong performance across its UnitedHealthcare and Optum segments.
Despite revenue expansion, the company experienced a significant decrease in earnings from operations, which fell 50% to $4.3 billionb. This decline is attributed to a substantial increase in medical costs, up 21% to $80 billion, driven by higher care patterns, increased unit costs, and the impacts of the Inflation Reduction Act on Medicare Part D plans. The medical care ratio (MCR) consequently rose to 89.9% from 85.2% in the prior year.
While the company continues to expand its reach, serving 795,000 more people primarily through Medicare Advantage, the pressure on medical costs and regulatory factors like Medicare Advantage funding reductions are impacting profitability. UnitedHealthcare's earnings from operations declined 57%c, while Optum Health saw an 88% decrease, highlighting the challenges in managing health care costs within these segments.
Conversely, Optum Insight and Optum Rx demonstrated resilience, with Optum Insight's earnings growing 46%d and Optum Rx remaining stable, underscoring the diverse performance across UNH's business units. Investors should closely monitor the company's ability to manage medical cost trends and navigate the evolving regulatory landscape.
02—Key points
Key Highlights
- Consolidated revenues grew 12% to $113.2 billion, driven by UnitedHealthcare (up 16%) and Optum (up 8%).
- Earnings from operations decreased significantly by 50% to $4.3 billion, impacted by elevated medical costs and regulatory factors.
- Medical costs surged 21% to $80 billion, leading to an increase in the Medical Care Ratio (MCR) to 89.9% from 85.2% year-over-year.
- UnitedHealthcare served 795,000 more people, primarily due to growth in Medicare Advantage.
- Optum Health experienced an 88% decrease in earnings from operations, largely due to Medicare Advantage funding reductions and rising medical costs.
- Optum Insight saw a substantial 46% increase in earnings from operations, indicating strong performance in this segment.
- Cash flows from operations for the nine months ended September 30, 2025, were $18.6 billion, although lower than the prior year's $21.8 billion.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2025, UnitedHealth Group Inc kept $0.02.
- Revenue$113.16B100.0%
- Cost of revenue−$12.57B11.1%
- Gross profit$100.59B88.9%
- Operating costs−$96.28B85.1%
- Operating income$4.32B3.8%
- Interest, other & tax−$1.97B1.7%
- Net income$2.35B2.1%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2025filed October 28, 2025Financial Statements
Q3 FY2025 against Q3 FY2024
| Line item | Q3 FY2025Q3 FY2024 | Change |
|---|---|---|
| Revenue | $113.16B$100.82B | +12.2% |
| Cost of Revenue | $12.57B$11.83B | +6.2% |
| Gross Profit | $100.59B$88.99B | +13.0% |
| SG&A Expenses | $15.22B$13.28B | +14.6% |
| Operating Expenses | $108.85B$92.11B | +18.2% |
| Operating Income | $4.32B$8.71B | −50.4% |
| Interest Expense | $1.00B$1.07B | −6.6% |
| Net Income | $2.35B$6.05B | −61.2% |
| EPS (Basic) | $2.59$6.56 | −60.5% |
| EPS (Diluted) | $2.59$6.51 | −60.2% |
| Shares Outstanding (Basic) | 906.00M923.00M | −1.8% |
| Shares Outstanding (Diluted) | 908.00M930.00M | −2.4% |
05—Questions
Frequently Asked Questions
What is the primary driver behind the significant decrease in UnitedHealth Group's earnings from operations?
The primary driver for the substantial decrease in earnings from operations is the significant increase in medical costs, which rose 21% year-over-year. This rise is attributed to higher care patterns, increased unit costs, and the impact of the Inflation Reduction Act on Medicare Part D plans, leading to a higher Medical Care Ratio (MCR).
How has UnitedHealthcare performed this quarter, and what are the key factors affecting its profitability?
UnitedHealthcare revenues grew 16%, supported by an increase of 795,000 served members, largely driven by Medicare Advantage growth. However, earnings from operations decreased by 57%. This decline is primarily due to Medicare Advantage funding reductions, elevated medical cost trends, market morbidity changes affecting individual exchange offerings, and other write-offs and settlements.
What is the outlook for Optum Health given its significant earnings decline?
Optum Health's earnings from operations experienced an 88% decrease. This is driven by Medicare Advantage funding reductions, the profile of newly added patients in value-based care arrangements, elevated medical cost trends, and business portfolio refinement. The company is facing pressure from insufficient funding rates in Medicaid and Medicare Advantage, impacting margins.
How is the company managing its liquidity and capital resources?
UnitedHealth Group maintains substantial liquidity, with cash, cash equivalents, available-for-sale debt securities, and marketable equity securities totaling $76.3 billion as of September 30, 2025. Cash flow from operations for the nine months was $18.6 billion. The company continues to fund its operations, pay dividends, and repurchase shares, indicating a belief in sufficient capital resources for future needs. However, the company notes that increased MCR is impacting the amount of dividends its regulated subsidiaries can pay to parent companies.
06—Continue